21 – 30 of 92
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Galectin-3-Binding Glycomimetics that Strongly Reduce Bleomycin-Induced Lung Fibrosis and Modulate Intracellular Glycan Recognition
- Contribution to journal › Article
- 2015
-
Mark
Various regimens for prophylactic treatment of patients with haemophilia
- Contribution to journal › Scientific review
-
Mark
Prevalence and outcome of gastrointestinal bleeding and use of acid suppressants in acutely ill adult intensive care patients
- Contribution to journal › Article
-
Mark
Strategies for reducing inhibitor formation in severe haemophilia
- Contribution to journal › Scientific review
-
Mark
Genetic risk factors for inhibitors in haemophilia A
- Contribution to journal › Scientific review
-
Mark
Switching treatments in haemophilia: is there a risk of inhibitor development?
- Contribution to journal › Scientific review
-
Mark
Non-genetic risk factors and their influence on the management of patients in the clinic
- Contribution to journal › Scientific review
-
Mark
Strategies for inhibitor treatment and costs in the short and long term: a critical evaluation of recent clinical studies
- Contribution to journal › Scientific review
-
Mark
Haemophilia in Sweden – Studies on mutations and clinical implications
- Thesis › Doctoral thesis (compilation)
- 2014
-
Mark
Immunosuppressive agents in the treatment of inhibitors in congenital haemophilia A and B - a systematic literature review
- Contribution to journal › Scientific review
